A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 26,425 shares of MEDP stock, worth $9.21 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
26,425
Previous 4,661 466.94%
Holding current value
$9.21 Million
Previous $1.92 Million 359.2%
% of portfolio
0.05%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$320.58 - $457.29 $6.98 Million - $9.95 Million
21,764 Added 466.94%
26,425 $8.81 Million
Q2 2024

Aug 09, 2024

SELL
$372.0 - $424.34 $685,968 - $782,482
-1,844 Reduced 28.35%
4,661 $1.92 Million
Q1 2024

May 09, 2024

SELL
$284.87 - $413.31 $433,572 - $629,057
-1,522 Reduced 18.96%
6,505 $2.63 Million
Q4 2023

Feb 09, 2024

SELL
$227.52 - $312.68 $2.71 Million - $3.72 Million
-11,893 Reduced 59.7%
8,027 $2.46 Million
Q3 2023

Nov 13, 2023

BUY
$233.98 - $281.67 $1.39 Million - $1.68 Million
5,956 Added 42.65%
19,920 $4.82 Million
Q2 2023

Aug 10, 2023

BUY
$187.26 - $240.17 $2.05 Million - $2.63 Million
10,940 Added 361.77%
13,964 $3.35 Million
Q1 2023

May 09, 2023

SELL
$174.31 - $239.52 $3.91 Million - $5.37 Million
-22,430 Reduced 88.12%
3,024 $568,000
Q4 2022

Feb 10, 2023

SELL
$153.06 - $226.57 $1.29 Million - $1.91 Million
-8,430 Reduced 24.88%
25,454 $5.41 Million
Q3 2022

Nov 10, 2022

BUY
$145.13 - $182.49 $306,949 - $385,966
2,115 Added 6.66%
33,884 $5.33 Million
Q2 2022

Aug 05, 2022

BUY
$130.2 - $168.03 $1.26 Million - $1.63 Million
9,688 Added 43.87%
31,769 $4.76 Million
Q1 2022

May 12, 2022

SELL
$138.87 - $214.31 $431,885 - $666,504
-3,110 Reduced 12.35%
22,081 $3.61 Million
Q4 2021

Feb 10, 2022

BUY
$182.74 - $227.9 $675,407 - $842,318
3,696 Added 17.19%
25,191 $5.48 Million
Q3 2021

Nov 12, 2021

BUY
$170.18 - $198.21 $2.07 Million - $2.42 Million
12,185 Added 130.88%
21,495 $4.07 Million
Q2 2021

Aug 12, 2021

BUY
$158.62 - $194.3 $1.48 Million - $1.81 Million
9,310 New
9,310 $1.64 Million
Q3 2019

Nov 13, 2019

SELL
$62.38 - $85.89 $5.33 Million - $7.34 Million
-85,425 Closed
0 $0
Q2 2019

Aug 07, 2019

SELL
$53.64 - $65.42 $645,342 - $787,068
-12,031 Reduced 12.35%
85,425 $5.59 Million
Q1 2019

May 08, 2019

SELL
$49.38 - $70.58 $3.26 Million - $4.66 Million
-65,977 Reduced 40.37%
97,456 $5.75 Million
Q4 2018

Feb 12, 2019

BUY
$46.97 - $63.98 $1.96 Million - $2.67 Million
41,762 Added 34.32%
163,433 $8.65 Million
Q3 2018

Nov 13, 2018

BUY
$43.25 - $63.74 $4.55 Million - $6.71 Million
105,271 Added 641.9%
121,671 $7.29 Million
Q2 2018

Aug 02, 2018

BUY
$34.03 - $45.46 $269,687 - $360,270
7,925 Added 93.51%
16,400 $705,000
Q1 2018

May 14, 2018

BUY
$32.03 - $39.05 $271,454 - $330,948
8,475 New
8,475 $296,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.8B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.